Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy is a clinical research site located in Durham, North Carolina, United States 27705.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Anemia, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis.
Sponsors: Incyte Corporation.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy has 2 clinical trials on record, with 2 currently active. Their work covers Anemia, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis.
Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.